FDA device listing
Dexcom G6 Glucose Program Continuous Glucose Monitoring System
FDA device listing 1086177006 · DEXCOM, INC.
Key facts
| Proprietary names | Dexcom G6 Glucose Program Continuous Glucose Monitoring System |
|---|---|
| Owner/operator | DEXCOM, INC. |
| Owner/operator number | 9071756 |
| Premarket submissions | K221259 |
| Product codes | QBJ, QDK, QII |
| Device names | QBJ - Integrated Continuous Glucose Monitoring System, Factory Calibrated, QDK - Integrated Continuous Glucose Monitoring System For Non-Intensive Diabetes Management, QII - Integrated Continuous Glucose Monitoring System For Professional Directed Retrospective Or Real-Time Use |
| Device class | Class II |
| Classification regulations (21 CFR) | 862.1355 |
| Review panels | Clinical Chemistry |
| Registered establishments | Dexcom, Inc., DEXCOM, INC. |
| Establishment registrations | 3004753838, 3013435121 |
| FEI numbers | 3004753838, 3013435121 |
| Establishment operations | Complaint File Establishment, Manufacturer, Specification Developer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- 10–99 UDI devices (GUDID) under the same submission
- 1–9 Device listings citing the same submission
- Yes Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database